Marshall Summar

Chief Executive Officer, Uncommon Cures, LLC

Marshall Summar is a prominent figure in the field of rare diseases and clinical research. He currently serves as the Chief Executive Officer of Uncommon Cures LLC, a position he has held since September 2022.2

Professional Background

Dr. Summar has an extensive career in pediatrics, genetics, and rare disease research:

He was the Founding Director of the Rare Disease Institute at Children's National Hospital from 2017 to 2022.2
He served as Chief of the Division of Genetics and Metabolism at Children's National Hospital from 2010 to 2022.2
He is a Professor of Pediatrics at George Washington University.2
Previously, he worked at Vanderbilt University Medical Center from 1988 to 2010, where he started the metabolic genetics program.2

Leadership in Rare Disease Organizations

Dr. Summar has held several leadership positions in rare disease organizations:

He was the Chairman of the Board for the National Organization for Rare Disorders from 2016 to 2020.2
He served as President of the Board of Directors for the Society for Inherited Metabolic Disease from 2015 to 2017.2
He is currently a member of the NIH National Center for Advancing Translational Sciences Advisory Council.2

Uncommon Cures LLC

At Uncommon Cures, Dr. Summar leads a company focused on innovating rare disease clinical trials:

The company aims to reduce the cost and time to completion of rare disease clinical trials.3
They use centralized facilities, patient-centric low-impact study design, and remote monitoring.3
Uncommon Cures brings together a team of rare disease physicians with over 75 years of combined experience.3

Education and Expertise

Dr. Summar's educational background includes:

M.D. from the University of Tennessee-Health Science Center (1981-1985)2
B.S. in Molecular Biology from Vanderbilt University (1977-1981)2
Residency in Pediatrics and Fellowship in Biochemical and Clinical Genetics at Vanderbilt University School of Medicine2

He is well-known for his pioneering work in caring for children diagnosed with rare diseases.1 4